SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001140361-24-033602
Filing Date
2024-07-19
Accepted
2024-07-19 16:30:11
Documents
2
Group Members
INVESTOR ABMHC SWEDEN ABMOLNLYCKE ABMOLNLYCKE HOLDING ABPATRICIA INDUSTRIES ABROTCA AB

Document Format Files

Seq Description Document Type Size
1 SC 13D ef20032647_sc13d.htm SC 13D 369595
2 EXHIBIT 99.1 ef20032647_ex99-1.htm EX-99.1 26689
  Complete submission text file 0001140361-24-033602.txt   397977
Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Subject) CIK: 0001593984 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88069 | Film No.: 241128115
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address GAMLESTADSVAGEN 3C GOTEBORG V7 415 11
Business Address GAMLESTADSVAGEN 3C GOTEBORG V7 415 11 46 73 773 3879
Molnlycke Health Care AB (Filed by) CIK: 0002030481 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC 13D